Ogawa T - Search Results

1

Locomotor hyperactivity following prenatal exposure to 5-bromo-2'-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations.

Kuwagata M, Muneoka KT, Ogawa T, Takigawa M, Nagao T. Kuwagata M, et al. Among authors: ogawa t. Toxicol Lett. 2004 Aug 30;152(1):63-71. doi: 10.1016/j.toxlet.2004.03.019. Toxicol Lett. 2004. PMID: 15294348

2

The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.

Kuwagata M, Ogawa T, Nagata T, Shioda S. Kuwagata M, et al. Among authors: ogawa t. Neurotoxicology. 2007 Jul;28(4):780-9. doi: 10.1016/j.neuro.2006.07.017. Epub 2006 Aug 1. Neurotoxicology. 2007. PMID: 16956662

3

Effects of the genotoxic agent 5-bromo-2'-deoxyuridine with or without pre-pubertal gonadectomy on brain monoamines and their metabolites in female rats.

Kuwagata M, Muneoka K, Ogawa T, Shioda S. Kuwagata M, et al. Among authors: ogawa t. Brain Res Bull. 2011 May 30;85(3-4):207-11. doi: 10.1016/j.brainresbull.2011.03.005. Epub 2011 Mar 15. Brain Res Bull. 2011. PMID: 21414389

4

Hyperactivity induced by prenatal BrdU exposure across several experimental conditions.

Kuwagata M, Ogawa T, Muneoka K, Shioda S. Kuwagata M, et al. Among authors: ogawa t. Congenit Anom (Kyoto). 2011 Dec;51(4):177-82. doi: 10.1111/j.1741-4520.2011.00331.x. Congenit Anom (Kyoto). 2011. PMID: 22103457

5

Neuropathological examination of fetal rat brain in the 5-bromo-2'-deoxyuridine-induced neurodevelopmental disorder model.

Ogawa T, Kuwagata M, Muneoka KT, Shioda S. Ogawa T, et al. Congenit Anom (Kyoto). 2005 Mar;45(1):14-20. doi: 10.1111/j.1741-4520.2005.00055.x. Congenit Anom (Kyoto). 2005. PMID: 15737126

6

Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model.

Muneoka K, Kuwagata M, Iwata M, Shirayama Y, Ogawa T, Takigawa M. Muneoka K, et al. Among authors: ogawa t. Congenit Anom (Kyoto). 2006 Sep;46(3):155-9. doi: 10.1111/j.1741-4520.2006.00119.x. Congenit Anom (Kyoto). 2006. PMID: 16922923

7

Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy.

Ogawa T, Kuwagata M, Hori Y, Shioda S. Ogawa T, et al. Toxicol Lett. 2007 Nov 1;174(1-3):18-24. doi: 10.1016/j.toxlet.2007.08.006. Epub 2007 Aug 19. Toxicol Lett. 2007. PMID: 17900830

8

Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine.

Orito K, Morishima A, Ogawa T, Muneoka K, Kuwagata M, Takata J, Mishima K, Fujiwara M. Orito K, et al. Among authors: ogawa t. Int J Dev Neurosci. 2009 Feb;27(1):81-6. doi: 10.1016/j.ijdevneu.2008.09.002. Epub 2008 Sep 11. Int J Dev Neurosci. 2009. PMID: 18834934

9

Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study.

Kuwagata M, Ogawa T, Shioda S, Nagata T. Kuwagata M, et al. Among authors: ogawa t. Int J Dev Neurosci. 2009 Jun;27(4):399-405. doi: 10.1016/j.ijdevneu.2009.01.006. Epub 2009 Jan 29. Int J Dev Neurosci. 2009. PMID: 19460635

10

Abnormal brain function of the rat neonate in a prenatal 5-bromo-2'-deoxyuridine (BrdU)-induced developmental disorder model.

Ogawa T, Kuwagata M, Muneoka K, Wakai C, Senuma M, Kubo H, Shioda S. Ogawa T, et al. Int J Dev Neurosci. 2012 Oct;30(6):507-15. doi: 10.1016/j.ijdevneu.2012.05.002. Epub 2012 May 17. Int J Dev Neurosci. 2012. PMID: 22609825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,932 results

Search Page

Filters